newsfilter
← Latest News
PR Newswire·

IsoPlexis Announces Pricing of Initial Public Offering

BRANFORD, Conn., Oct. 7, 2021 /PRNewswire/ -- IsoPlexis Corporation ("IsoPlexis"), a leader in functional single-cell proteomics, today announced the pricing of its initial public offering of 8,333,000 shares of common stock at a public offering price